Stories of Discovery, Innovation, and Impact
Neurology
Tuberculosis Vaccine Changes Brain’s Immune Environment and Alzheimer’s Biomarkers in Older Adults
Cancer
Genetic Makeup Affects Whether Patients Experience Benefits or Side Effects of Immune Cell Therapy for Cancer
Heart Conditions
Mass General Brigham Researchers Awarded ARPA-H Funding to Scale Genome Editing for Rare Genetic Vascular Diseases
Featured Story
Preclinical Study Suggests Restoring Inhibitory Neuron Plasticity May Reverse Neurodevelopmental Disorder Symptoms
A team led by investigators at Mass General Brigham identified genes involved in these neurons’ plasticity and then demonstrated benefits to overexpressing one key gene.
the photo depicts a person holding tablet displaying an AI-generated hologram
Shown in yellow, a parvalbumin interneuron in hippocampal CA3/CA2. Credit: Sahay lab.
About Mass General Brigham Research
Transforming Discovery Together
We drive transformative innovation in an environment where the best and the brightest researchers, clinicians, staff, and trainees collaborate across the enterprise and with partners around the world. Patients are at the center of what we do; we shape the future of biomedical research to create revolutionary solutions to improve the health of people everywhere.
center
Clinical Research
Advancing patient-centered research and innovation
We know the importance of research and innovation, and our patients' role in it. Our founding hospitals have a long tradition of medical breakthroughs, and you can be a part of the next discovery.
primary
internal-arrow
Explore clinical research opportunities
$2.7 billion+
annual research budget
info-card, palette-teal
14
Nobel Laureats
info-card, palette-white
200+
years of leading innovative science
info-card, palette-deep-blue
As a world-recognized leader in research, Mass General Brigham is home to one of the largest hospital system-based research medical centers in the U.S. Our researchers and clinicians are conducting thousands of studies in every major medical therapeutic and technology discipline.
statement-card, palette-dark-teal, emphasize
No. 1
among 60 organizations and centers in the Cure Innovation Index
info-card, palette-white